No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / secondary
-
Male
-
Neoplasms, Germ Cell and Embryonal / drug therapy
-
Seminoma / drug therapy*
-
Seminoma / secondary
-
Testicular Neoplasms / drug therapy*
-
Testicular Neoplasms / pathology
-
Treatment Failure
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
durvalumab
-
tremelimumab
Associated data
-
ClinicalTrials.gov/NCT03081923